CRISPR-based epigenetic modifiers
CRISPR-based epigenetic modifiers
批准号:
9480886
负责人:
DAVID J SEGAL
金额:
$6.85万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-15 至 2018-05-31
关键词:
Advanced DevelopmentAffectBindingBiologicalCRISPR/Cas technologyCancer EtiologyCell divisionChemicalsClinicalCloningClustered Regularly Interspaced Short Palindromic RepeatsComplexDNADNA Binding DomainDNA Modification ProcessDNA SequenceDevelopmentDrug resistanceEngineeringEnhancersEnzymesEpigenetic ProcessEventFoundationsGene ExpressionGene Expression ProfileGene Expression RegulationGeneticGenetic Enhancer ElementGoalsGoldGuide RNAHistonesLeadLengthMalignant NeoplasmsMeasuresModificationOncogenesPerformancePharmaceutical PreparationsPhaseProteinsPublicationsReagentRecruitment ActivityRegulationRegulator GenesReportingSiteSpecificitySystemWritingZinc Fingersanticancer researchbasecancer therapydesignepigenomeexperimental studyfallsgenetic variantgenome editinggenome-wideinfancyinterestnovel therapeuticsprogramspromotersuccesstooltumor heterogeneitytumorigenesis
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1073/pnas.1716945115
发表时间:
2018-02-27
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Gallego-Bartolomé J, Gardiner J, Liu W, Papikian A, Ghoshal B, Kuo HY, Zhao JM, Segal DJ, Jacobsen SE]
通讯作者:
Jacobsen SE
DOI:
10.1093/nar/gkx578
发表时间:
2017-09-29
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[O'Geen H, Ren C, Nicolet CM, Perez AA, Halmai J, Le VM, Mackay JP, Farnham PJ, Segal DJ]
通讯作者:
Segal DJ
Genome Editing and Biological Effects Testing Component
-
批准号:10773949
-
项目类别:
-
资助金额:$65.19万
-
财政年份:2023
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10472034
-
项目类别:
-
资助金额:$47.13万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10447268
-
项目类别:
-
资助金额:$46.4万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools: Equipment Supplement
-
批准号:10330336
-
项目类别:
-
资助金额:$9.72万
-
财政年份:2021
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:9810511
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10380051
-
项目类别:
-
资助金额:$104.38万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
-
批准号:9770048
-
项目类别:
-
资助金额:$116.87万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Innovative Translational Imaging Technologies to Monitor Genome Edited Cells in Vivo
-
批准号:10017228
-
项目类别:
-
资助金额:$22.79万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10599929
-
项目类别:
-
资助金额:$93.79万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
-
批准号:9905568
-
项目类别:
-
资助金额:$116.14万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Determinants of Persistence in Epigenetic Editing
-
批准号:9920184
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
Genome Editing Testing Core
-
批准号:10133176
-
项目类别:
-
资助金额:$98.39万
-
财政年份:2019
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifier
-
批准号:9369533
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2017
-
负责人:DAVID J SEGAL
-
依托单位:
CRISPR-based epigenetic modifiers
-
批准号:9301498
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2016
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8641394
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8449290
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8245004
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
NextGen DNA Binding Proteins Based on TAL Domains
-
批准号:8083281
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2011
-
负责人:DAVID J SEGAL
-
依托单位:
Towards Gene Therapy for Angelman Syndrome
-
批准号:7970962
-
项目类别:
-
资助金额:$17.91万
-
财政年份:2010
-
负责人:DAVID J SEGAL
-
依托单位:
Towards Gene Therapy for Angelman Syndrome
-
批准号:8139031
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2010
-
负责人:DAVID J SEGAL
-
依托单位:
海外基金